Connection

Robert Adams to Anemia, Sickle Cell

This is a "connection" page, showing publications Robert Adams has written about Anemia, Sickle Cell.
Connection Strength

10.806
  1. Transcranial Doppler Screening in a Current Cohort of Children With Sickle Cell Anemia: Results From the DISPLACE Study. J Pediatr Hematol Oncol. 2021 11 01; 43(8):e1062-e1068.
    View in: PubMed
    Score: 0.601
  2. New approaches to genetic predisposition for hemorrhagic stroke in sickle cell disease. J Clin Hypertens (Greenwich). 2018 06; 20(6):1078-1079.
    View in: PubMed
    Score: 0.474
  3. Coexistent Sickle Cell Disease Has No Impact on the Safety or Outcome of Lytic Therapy in Acute Ischemic Stroke: Findings From Get With The Guidelines-Stroke. Stroke. 2017 03; 48(3):686-691.
    View in: PubMed
    Score: 0.433
  4. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Lancet. 2016 Feb 13; 387(10019):661-670.
    View in: PubMed
    Score: 0.399
  5. Neurologic complications of sickle cell disease. Handb Clin Neurol. 2014; 120:1015-25.
    View in: PubMed
    Score: 0.349
  6. Prevention of stroke in sickle cell anemia. J Law Med Ethics. 2014; 42(2):135-8.
    View in: PubMed
    Score: 0.349
  7. Toward a stroke-free childhood in sickle cell disease: the 2013 Sherman Lecture. Stroke. 2013 Oct; 44(10):2930-4.
    View in: PubMed
    Score: 0.342
  8. Trends in comorbid sickle cell disease among stroke patients. J Neurol Sci. 2012 Feb 15; 313(1-2):86-91.
    View in: PubMed
    Score: 0.299
  9. Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injury. Blood. 2009 Nov 19; 114(21):4632-8.
    View in: PubMed
    Score: 0.259
  10. Big strokes in small persons. Arch Neurol. 2007 Nov; 64(11):1567-74.
    View in: PubMed
    Score: 0.228
  11. Intra-individual variation in blood flow velocities in cerebral arteries of children with sickle cell disease. Pediatr Blood Cancer. 2007 Sep; 49(3):318-22.
    View in: PubMed
    Score: 0.225
  12. Transcranial Doppler ultrasonography in adults with sickle cell disease. Neurology. 2006 Aug 22; 67(4):572-4.
    View in: PubMed
    Score: 0.210
  13. Pathophysiology and treatment of stroke in sickle-cell disease: present and future. Lancet Neurol. 2006 Jun; 5(6):501-12.
    View in: PubMed
    Score: 0.206
  14. Trials in sickle cell disease. Pediatr Neurol. 2006 Jun; 34(6):450-8.
    View in: PubMed
    Score: 0.206
  15. Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke. 2006 Jun; 37(6):1424-6.
    View in: PubMed
    Score: 0.205
  16. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005 Dec 29; 353(26):2769-78.
    View in: PubMed
    Score: 0.200
  17. TCD in sickle cell disease: an important and useful test. Pediatr Radiol. 2005 Mar; 35(3):229-34.
    View in: PubMed
    Score: 0.189
  18. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Pediatr Radiol. 2005 Jan; 35(1):66-72.
    View in: PubMed
    Score: 0.185
  19. Sickle cell disease: primary stroke prevention. CNS Spectr. 2004 Jun; 9(6):445-9.
    View in: PubMed
    Score: 0.180
  20. Stroke and conversion to high risk in children screened with transcranial Doppler ultrasound during the STOP study. Blood. 2004 May 15; 103(10):3689-94.
    View in: PubMed
    Score: 0.176
  21. Sickle cell disease and stroke: primary prevention and transcranial Doppler. Ann Neurol. 2003 Nov; 54(5):559-63.
    View in: PubMed
    Score: 0.173
  22. Hemorrhagic Stroke in Children and Adults With Sickle Cell Anemia: The Post-STOP Cohort. Stroke. 2022 11; 53(11):e463-e466.
    View in: PubMed
    Score: 0.160
  23. Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia. J Pediatr Hematol Oncol Nurs. 2022 Jul-Aug; 39(4):209-220.
    View in: PubMed
    Score: 0.154
  24. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Br J Haematol. 2021 11; 195(4):612-620.
    View in: PubMed
    Score: 0.147
  25. Stroke prevention and treatment in sickle cell disease. Arch Neurol. 2001 Apr; 58(4):565-8.
    View in: PubMed
    Score: 0.144
  26. Sickle cell and the brain. Hematology Am Soc Hematol Educ Program. 2001; 31-46.
    View in: PubMed
    Score: 0.142
  27. Transcranial Doppler (TCD) screening for stroke prevention in sickle cell anemia: pitfalls in technique variation. Pediatr Radiol. 2000 Nov; 30(11):733-8.
    View in: PubMed
    Score: 0.140
  28. Practice patterns for neuroimaging and transfusion therapy for management of neurologic complications in sickle cell anemia: DISPLACE consortium. Pediatr Blood Cancer. 2020 11; 67(11):e28569.
    View in: PubMed
    Score: 0.139
  29. Multicenter comparison of magnetic resonance imaging and transcranial Doppler ultrasonography in the evaluation of the central nervous system in children with sickle cell disease. J Pediatr Hematol Oncol. 2000 Jul-Aug; 22(4):335-9.
    View in: PubMed
    Score: 0.137
  30. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. J Child Neurol. 2000 May; 15(5):344-9.
    View in: PubMed
    Score: 0.135
  31. Practice patterns for stroke prevention using transcranial Doppler in sickle cell anemia: DISPLACE Consortium. Pediatr Blood Cancer. 2020 04; 67(4):e28172.
    View in: PubMed
    Score: 0.133
  32. Ischemic stroke in children and young adults with sickle cell disease in the post-STOP era. Am J Hematol. 2019 12; 94(12):1335-1343.
    View in: PubMed
    Score: 0.131
  33. Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clin Trials. 2019 02; 16(1):20-31.
    View in: PubMed
    Score: 0.122
  34. Incomplete implementation of guideline-based stroke prevention therapy in sickle cell disease. Am J Hematol. 2018 09; 93(9):E222-E224.
    View in: PubMed
    Score: 0.120
  35. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998 Jul 02; 339(1):5-11.
    View in: PubMed
    Score: 0.119
  36. Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition. Br J Haematol. 2018 04; 181(2):242-251.
    View in: PubMed
    Score: 0.117
  37. Stroke prevention trial in sickle cell anemia. Control Clin Trials. 1998 Feb; 19(1):110-29.
    View in: PubMed
    Score: 0.116
  38. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol. 1997 Nov; 42(5):699-704.
    View in: PubMed
    Score: 0.114
  39. Internal carotid artery occlusion in a child with sickle cell disease: case report and immunohistochemical study. J Pediatr Hematol Oncol. 1997 Sep-Oct; 19(5):455-8.
    View in: PubMed
    Score: 0.113
  40. Transcranial doppler re-screening of subjects who participated in STOP and STOP II. Am J Hematol. 2016 12; 91(12):1191-1194.
    View in: PubMed
    Score: 0.106
  41. TCD in sickle cell disease. J Pediatr Hematol Oncol. 1996 Aug; 18(3):331-4.
    View in: PubMed
    Score: 0.104
  42. Needs Assessment for Patients with Sickle Cell Disease in South Carolina, 2012. Public Health Rep. 2016 Jan-Feb; 131(1):108-16.
    View in: PubMed
    Score: 0.100
  43. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke. PLoS One. 2015; 10(8):e0134193.
    View in: PubMed
    Score: 0.098
  44. Sickle cell disease and stroke. J Child Neurol. 1995 Mar; 10(2):75-6.
    View in: PubMed
    Score: 0.095
  45. Neuropsychological impairment in children with sickle cell anemia and cerebrovascular accidents. Clin Pediatr (Phila). 1994 Sep; 33(9):517-24.
    View in: PubMed
    Score: 0.091
  46. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Blood. 2014 Aug 07; 124(6):891-8.
    View in: PubMed
    Score: 0.090
  47. Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 1994 Apr; 45(4):279-82.
    View in: PubMed
    Score: 0.089
  48. Frequent red cell transfusions reduced vascular endothelial activation and thrombogenicity in children with sickle cell anemia and high stroke risk. Am J Hematol. 2014 Jan; 89(1):47-51.
    View in: PubMed
    Score: 0.087
  49. Intracranial blood flow velocities in patients with sickle cell disease and ?-thalassemia intermedia. Am J Hematol. 2013 Sep; 88(9):825.
    View in: PubMed
    Score: 0.085
  50. Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood. 2013 Apr 18; 121(16):3237-45.
    View in: PubMed
    Score: 0.082
  51. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke. 1992 Aug; 23(8):1073-7.
    View in: PubMed
    Score: 0.079
  52. Plasma BDNF and PDGF-AA levels are associated with high TCD velocity and stroke in children with sickle cell anemia. Cytokine. 2012 Oct; 60(1):302-8.
    View in: PubMed
    Score: 0.078
  53. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia. Blood Cells Mol Dis. 2011 Aug 15; 47(2):125-8.
    View in: PubMed
    Score: 0.073
  54. Discontinuing prophylactic transfusions increases the risk of silent brain infarction in children with sickle cell disease: data from STOP II. Blood. 2011 Jul 28; 118(4):894-8.
    View in: PubMed
    Score: 0.073
  55. Genetic predictors for stroke in children with sickle cell anemia. Blood. 2011 Jun 16; 117(24):6681-4.
    View in: PubMed
    Score: 0.072
  56. Effect of transfusion therapy on transcranial Doppler ultrasonography velocities in children with sickle cell disease. Pediatr Blood Cancer. 2011 May; 56(5):777-82.
    View in: PubMed
    Score: 0.071
  57. Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer. 2010 Feb; 54(2):256-9.
    View in: PubMed
    Score: 0.067
  58. Cerebral vessel stenosis in sickle cell disease: criteria for detection by transcranial Doppler. Am J Pediatr Hematol Oncol. 1990; 12(3):277-82.
    View in: PubMed
    Score: 0.066
  59. Plasma interleukin-1beta concentration is associated with stroke in sickle cell disease. Cytokine. 2010 Jan; 49(1):39-44.
    View in: PubMed
    Score: 0.065
  60. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology. 2009 Apr 14; 72(15):1316-21.
    View in: PubMed
    Score: 0.063
  61. MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer. 2008 Nov; 51(5):643-6.
    View in: PubMed
    Score: 0.061
  62. Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI. Neurology. 1988 Jul; 38(7):1012-7.
    View in: PubMed
    Score: 0.060
  63. Detection of cerebral vasculopathy in sickle cell disease using transcranial Doppler ultrasonography and magnetic resonance imaging. Case report. Stroke. 1988 Apr; 19(4):518-20.
    View in: PubMed
    Score: 0.059
  64. Obstacles to primary stroke prevention in children with sickle cell disease. Neurology. 2006 Sep 26; 67(6):1098-9.
    View in: PubMed
    Score: 0.053
  65. Elevated blood flow velocity in the anterior cerebral artery and stroke risk in sickle cell disease: extended analysis from the STOP trial. Br J Haematol. 2006 Aug; 134(3):333-9.
    View in: PubMed
    Score: 0.052
  66. Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results. Blood. 2006 Aug 01; 108(3):847-52.
    View in: PubMed
    Score: 0.052
  67. Stroke in sickle cell disease. J Med Assoc Ga. 1986 May; 75(5):271-4.
    View in: PubMed
    Score: 0.051
  68. Declining stroke rates in Californian children with sickle cell disease. Blood. 2004 Jul 15; 104(2):336-9.
    View in: PubMed
    Score: 0.044
  69. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study. Blood. 2004 Apr 01; 103(7):2822-6.
    View in: PubMed
    Score: 0.044
  70. Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol. 2003 Aug; 25(8):622-8.
    View in: PubMed
    Score: 0.042
  71. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case-control association study and genomewide screen. BMC Med Genet. 2003 Jul 18; 4:6.
    View in: PubMed
    Score: 0.042
  72. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001 Dec; 58(12):2017-21.
    View in: PubMed
    Score: 0.038
  73. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. J Pediatr. 2001 Dec; 139(6):785-9.
    View in: PubMed
    Score: 0.038
  74. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial. Transfusion. 2001 Sep; 41(9):1086-92.
    View in: PubMed
    Score: 0.037
  75. Correlation of abnormal intracranial vessel velocity, measured by transcranial Doppler ultrasonography, with abnormal conjunctival vessel velocity, measured by computer-assisted intravital microscopy, in sickle cell disease. Blood. 2001 Jun 01; 97(11):3401-4.
    View in: PubMed
    Score: 0.036
  76. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995 Jun; 126(6):896-9.
    View in: PubMed
    Score: 0.024
  77. Sickle cell anemia and other hemoglobinopathies. Semin Neurol. 1991 Dec; 11(4):314-28.
    View in: PubMed
    Score: 0.019
  78. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 Jan; 42(1):227-76.
    View in: PubMed
    Score: 0.017
  79. Delayed intracranial hemorrhage following cerebral infarction in sickle cell anemia. J Assoc Acad Minor Phys. 1990; 1(3):79-82.
    View in: PubMed
    Score: 0.017
  80. MR and CT investigation of cerebrovascular disease in sickle cell patients. AJNR Am J Neuroradiol. 1986 Nov-Dec; 7(6):1043-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.